Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma

Gastroenterology

Volumn 122, Issue 7, 2002, Pages 1815-1821

  VazquezSequeiros, Enrique ^a   Wang, Linan ^a   Burgart, Lawrence ^a   Harmsen, William ^a   Zinsmeister, Alan ^a   Allen, Mark ^a   Jondal, Mary ^a   Wiersema, Maurits ^a  

^a General Thoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; KERATIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036086452     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.33665     Document Type: Article

References (33)

1. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
2. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
3. The changing epidemiology of esophageal cancer
4. Esophageal carcinoma: Current controversies
5. The prognosis of esophageal carcinoma staged unresectable (T4) by endosonography
6. Proposed revision of the staging classification for esophageal cancer
7. Carcinoma of the esophagus. Prognostic significance of histologic type
8. Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53
9. Transhiatal versus transthoracic esophagectomy for clinical stage I esophageal carcinoma
10. Pattern of recurrence after oesophageal resection for cancer: Clinical implications
11. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia
12. Relationships between operative approaches and outcomes in esophageal cancer
13. Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer
14. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
15. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
16. Multimodality therapy for esophageal cancer
17. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
18. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
19. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer
20. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes
21. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction
22. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma
23. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma
24. Recommendations for processing and reporting of lymph node specimens’submitted for evaluation of metastatic disease
25. Significance of circumferential resection margin involvement after oesophagectomy for cancer
26. Squamous carcinoma of the oesophagus: Histological criteria and their prognostic significance
27. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy
28. The number of lymph node metastases influences survival in esophageal cancer
29. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction
30. Prognostic value of lymph node micrometastases detected by immunohistochemistry. Study of 168 cases of breast cancer with a 10 year follow up
31. Immunohistochemical evaluation of lymph node micrometastasis from gastric carcinomas
32. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia